Skip to content
Vanity or Vice

Every file · 378

The Index

The section pages are curated, which means somebody decided what belonged. This page did not. Everything published, newest first, including the pieces that never fit a theme and were never going to.

Aug 16, 2026 · Treatment Room

BPC-157 Heals Rats Beautifully

BPC-157 is one of the most-searched experimental peptides in 2026 and is marketed for tendon, ligament, gut, wound, and general recovery. The human evidence and safety…

Aug 16, 2026 · Claims & Evidence

What NMN and NR Buy You Is a Higher Blood Metabolite

NAD+ boosters reliably create biochemical activity in humans. The harder 2026 question is whether that activity improves cognition, metabolism, function, or healthspan enough to justify the…

Aug 16, 2026 · Treatment Room

The Skinny Shot Story Is Smaller Than Semaglutide

Semaglutide now has years of clinical evidence, multiple FDA-approved uses, and a new higher-dose Wegovy option. That makes precision more important: Ozempic is not a cosmetic…

Aug 16, 2026 · Treatment Room

Which Tirzepatide Are You Actually Buying?

Tirzepatide is an FDA-approved prescription drug with substantial clinical evidence. The harder 2026 question is what happens when the molecule name is stretched across obesity care,…

Aug 16, 2026 · Claims & Evidence

What the Marketing Photograph Crops Out

Beauty marketing often shows the benefit and crops out the denominator, maintenance, evidence transfer, comparison, exit and uncertainty. Put those missing parts back in the frame…

Aug 16, 2026 · Treatment Room

GHK-Cu, One Copper Peptide With Two Evidence Files

GHK-Cu has strong search momentum in both skincare and injectable peptide culture. A copper peptide in a serum and an injectable preparation share a molecule name,…

Aug 16, 2026 · Treatment Room

The Word Peptide Is Doing Too Much Work

Peptide therapy now covers everything from FDA-approved metabolic drugs to experimental compounds sold through wellness clinics and gray-market vendors. The category is popular. It is not…